Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Therapeutic Nuclear Medicines for these regions, from 2012 to 2023 (forecast), covering

China

USA

Europe

Japan

Korea

India

Global Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including

Cardinal Health Inc.

Mallinckrodt plc.

GE Healthcare

Lantheus Medical Imaging Inc.

Bayer AG

Bracco Imaging S.p.A

Eczacibasi-Monrol Nuclear Products

Nordion, Inc.

Advanced Accelerator Applications S.A.

IBA Molecular Imaging

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Beta Emitters

Alpha Emitters

Brachytherapy Products

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Therapeutic Nuclear Medicines for each application, including

Hospitals

Ambulatory Surgical Centers

Radiology Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Content

Table of Contents

1 Report Overview
    1.1 Definition and Specification
    1.2 Report Overview
        1.2.1 Manufacturers Overview
        1.2.2 Regions Overview
        1.2.3 Type Overview
        1.2.4 Application Overview
    1.3 Industrial Chain
        1.3.1 Therapeutic Nuclear Medicines Overall Industrial Chain
        1.3.2 Upstream
        1.3.3 Downstream
    1.4 Industry Situation
        1.4.1 Industrial Policy
        1.4.2 Product Preference
        1.4.3 Economic/Political Environment
    1.5 SWOT Analysis
2 Market Analysis by Types
    2.1 Overall Market Performance(Volume)
             2.1.1  Beta Emitters Market Performance (Volume)
             2.1.2   Alpha Emitters Market Performance (Volume)
             2.1.3   Brachytherapy Products Market Performance (Volume)
    2.2 Overall Market Performance(Value)
             2.1.1  Beta Emitters Market Performance (Value)
             2.1.2   Alpha Emitters Market Performance (Value)
             2.1.3   Brachytherapy Products Market Performance (Value)
3 Product Application Market
    3.1 Overall Market Performance (Volume)
             3.1.1  Hospitals Market Performance (Volume)
             3.1.2   Ambulatory Surgical Centers Market Performance (Volume)
             3.1.3   Radiology Clinics Market Performance (Volume)
4 Manufacturers Profiles/Analysis
    4.1  Cardinal Health Inc. 
        4.1.1  Cardinal Health Inc. Profiles 
        4.1.2  Cardinal Health Inc. Product Information 
        4.1.3  Cardinal Health Inc. Therapeutic Nuclear Medicines Business Performance  
        4.1.4  Cardinal Health Inc. Therapeutic Nuclear Medicines Business Development and Market Status  
    4.2   Mallinckrodt plc. 
        4.2.1   Mallinckrodt plc. Profiles 
        4.2.2   Mallinckrodt plc. Product Information 
        4.2.3   Mallinckrodt plc. Therapeutic Nuclear Medicines Business Performance  
        4.2.4   Mallinckrodt plc. Therapeutic Nuclear Medicines Business Development and Market Status  
    4.3   GE Healthcare 
        4.3.1   GE Healthcare Profiles 
        4.3.2   GE Healthcare Product Information 
        4.3.3   GE Healthcare Therapeutic Nuclear Medicines Business Performance  
        4.3.4   GE Healthcare Therapeutic Nuclear Medicines Business Development and Market Status  
    4.4   Lantheus Medical Imaging Inc. 
        4.4.1   Lantheus Medical Imaging Inc. Profiles 
        4.4.2   Lantheus Medical Imaging Inc. Product Information 
        4.4.3   Lantheus Medical Imaging Inc. Therapeutic Nuclear Medicines Business Performance  
        4.4.4   Lantheus Medical Imaging Inc. Therapeutic Nuclear Medicines Business Development and Market Status  
    4.5   Bayer AG 
        4.5.1   Bayer AG Profiles 
        4.5.2   Bayer AG Product Information 
        4.5.3   Bayer AG Therapeutic Nuclear Medicines Business Performance  
        4.5.4   Bayer AG Therapeutic Nuclear Medicines Business Development and Market Status  
    4.6   Bracco Imaging S.p.A 
        4.6.1   Bracco Imaging S.p.A Profiles 
        4.6.2   Bracco Imaging S.p.A Product Information 
        4.6.3   Bracco Imaging S.p.A Therapeutic Nuclear Medicines Business Performance  
        4.6.4   Bracco Imaging S.p.A Therapeutic Nuclear Medicines Business Development and Market Status  
    4.7   Eczacibasi-Monrol Nuclear Products 
        4.7.1   Eczacibasi-Monrol Nuclear Products Profiles 
        4.7.2   Eczacibasi-Monrol Nuclear Products Product Information 
        4.7.3   Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Business Performance  
        4.7.4   Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Business Development and Market Status  
    4.8   Nordion, Inc. 
        4.8.1   Nordion, Inc. Profiles 
        4.8.2   Nordion, Inc. Product Information 
        4.8.3   Nordion, Inc. Therapeutic Nuclear Medicines Business Performance  
        4.8.4   Nordion, Inc. Therapeutic Nuclear Medicines Business Development and Market Status  
    4.9   Advanced Accelerator Applications S.A. 
        4.9.1   Advanced Accelerator Applications S.A. Profiles 
        4.9.2   Advanced Accelerator Applications S.A. Product Information 
        4.9.3   Advanced Accelerator Applications S.A. Therapeutic Nuclear Medicines Business Performance  
        4.9.4   Advanced Accelerator Applications S.A. Therapeutic Nuclear Medicines Business Development and Market Status  
    4.10   IBA Molecular Imaging 
        4.10.1   IBA Molecular Imaging Profiles 
        4.10.2   IBA Molecular Imaging Product Information 
        4.10.3   IBA Molecular Imaging Therapeutic Nuclear Medicines Business Performance  
        4.10.4   IBA Molecular Imaging Therapeutic Nuclear Medicines Business Development and Market Status  
5 Market Performance for Manufacturers
    5.1 Global Therapeutic Nuclear Medicines Sales (K Units) and Market Share by Manufacturers 2013-2018
    5.2 Global Therapeutic Nuclear Medicines Revenue (M USD) and Market Share by Manufacturers 2013-2018
    5.3 Global Therapeutic Nuclear Medicines Price (USD/Unit) of Manufacturers 2013-2018
    5.4 Global Therapeutic Nuclear Medicines Gross Margin of Manufacturers 2013-2018
    5.5 Market Concentration
6 Regions Market Performance for Manufacturers
    6.1 China Market Performance for Manufacturers
        6.1.1 China Therapeutic Nuclear Medicines Sales (K Units) and Share of Manufacturers 2013-2018
        6.1.2 China Therapeutic Nuclear Medicines Revenue (M USD) and Share of Manufacturers 2013-2018
        6.1.3 China Therapeutic Nuclear Medicines Price (USD/Unit) of Manufacturers 2013-2018
        6.1.4 China Therapeutic Nuclear Medicines Gross Margin of Manufacturers 2013-2018
        6.1.5 Market Concentration
    6.2 USA Market Performance for Manufacturers
        6.2.1 USA Therapeutic Nuclear Medicines Sales (K Units) and Share of Manufacturers 2013-2018
        6.2.2 USA Therapeutic Nuclear Medicines Revenue (M USD) and Share of Manufacturers 2013-2018
        6.2.3 USA Therapeutic Nuclear Medicines Price (USD/Unit) of Manufacturers 2013-2018
        6.2.4 USA Therapeutic Nuclear Medicines Gross Margin of Manufacturers 2013-2018
        6.2.5 Market Concentration
    6.3 Europe Market Performance for Manufacturers
        6.3.1 Europe Therapeutic Nuclear Medicines Sales (K Units) and Share of Manufacturers 2013-2018
        6.3.2 Europe Therapeutic Nuclear Medicines Revenue (M USD) and Share of Manufacturers 2013-2018
        6.3.3 Europe Therapeutic Nuclear Medicines Price (USD/Unit) of Manufacturers 2013-2018
        6.3.4 Europe Therapeutic Nuclear Medicines Gross Margin of Manufacturers 2013-2018
        6.3.5 Market Concentration
    6.4 Japan Market Performance for Manufacturers
        6.4.1 Japan Therapeutic Nuclear Medicines Sales (K Units) and Share of Manufacturers 2013-2018
        6.4.2 Japan Therapeutic Nuclear Medicines Revenue (M USD) and Share of Manufacturers 2013-2018
        6.4.3 Japan Therapeutic Nuclear Medicines Price (USD/Unit) of Manufacturers 2013-2018
        6.4.4 Japan Therapeutic Nuclear Medicines Gross Margin of Manufacturers 2013-2018
        6.4.5 Market Concentration
    6.5 Korea Market Performance for Manufacturers
        6.5.1 Korea Therapeutic Nuclear Medicines Sales (K Units) and Share of Manufacturers 2013-2018
        6.5.2 Korea Therapeutic Nuclear Medicines Revenue (M USD) and Share of Manufacturers 2013-2018
        6.5.3 Korea Therapeutic Nuclear Medicines Price (USD/Unit) of Manufacturers 2013-2018
        6.5.4 Korea Therapeutic Nuclear Medicines Gross Margin of Manufacturers 2013-2018
        6.5.5 Market Concentration
    6.6 India Market Performance for Manufacturers
        6.6.1 India Therapeutic Nuclear Medicines Sales (K Units) and Share of Manufacturers 2013-2018
        6.6.2 India Therapeutic Nuclear Medicines Revenue (M USD) and Share of Manufacturers 2013-2018
        6.6.3 India Therapeutic Nuclear Medicines Price (USD/Unit) of Manufacturers 2013-2018
        6.6.4 India Therapeutic Nuclear Medicines Gross Margin of Manufacturers 2013-2018
        6.6.5 Market Concentration
    6.7 Southeast Asia Market Performance for Manufacturers
        6.7.1 Southeast Asia Therapeutic Nuclear Medicines Sales (K Units) and Share of Manufacturers 2013-2018
        6.7.2 Southeast Asia Therapeutic Nuclear Medicines Revenue (M USD) and Share of Manufacturers 2013-2018
        6.7.3 Southeast Asia Therapeutic Nuclear Medicines Price (USD/Unit) of Manufacturers 2013-2018
        6.7.4 Southeast Asia Therapeutic Nuclear Medicines Gross Margin of Manufacturers 2013-2018
        6.7.5 Market Concentration
    6.8 South America Market Performance for Manufacturers
        6.8.1 South America Therapeutic Nuclear Medicines Sales (K Units) and Share of Manufacturers 2013-2018
        6.8.2 South America Therapeutic Nuclear Medicines Revenue (M USD) and Share of Manufacturers 2013-2018
        6.8.3 South America Therapeutic Nuclear Medicines Price (USD/Unit) of Manufacturers 2013-2018
        6.8.4 South America Therapeutic Nuclear Medicines Gross Margin of Manufacturers 2013-2018
        6.8.5 Market Concentration
7 Global  Therapeutic Nuclear Medicines Market Performance (Sales Point)
    7.1 Global Therapeutic Nuclear Medicines Sales (K Units) and Market Share by Regions 2013-2018
    7.2 Global Therapeutic Nuclear Medicines Revenue (M USD) and Market Share by Regions 2013-2018
    7.3 Global Therapeutic Nuclear Medicines Price (USD/Unit) by Regions 2013-2018
    7.4 Global Therapeutic Nuclear Medicines Gross Margin by Regions 2013-2018
8 Development Trend for Regions (Sales Point)
    8.1 Global Therapeutic Nuclear Medicines Sales and Growth, Sales Value and Growth Rate2013-2018
    8.2 China Therapeutic Nuclear Medicines Sales and Growth, Sales Value and Growth Rate2013-2018
    8.3 USA Therapeutic Nuclear Medicines Sales and Growth, Sales Value and Growth Rate2013-2018
    8.4 Europe Therapeutic Nuclear Medicines Sales and Growth, Sales Value and Growth Rate2013-2018
    8.5 Japan Therapeutic Nuclear Medicines Sales and Growth, Sales Value and Growth Rate2013-2018
    8.6 Korea Therapeutic Nuclear Medicines Sales and Growth, Sales Value and Growth Rate2013-2018
    8.7 India Therapeutic Nuclear Medicines Sales and Growth, Sales Value and Growth Rate2013-2018
    8.8 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth, Sales Value and Growth Rate2013-2018
    8.8 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth, Sales Value and Growth Rate2013-2018
9 Upstream Source, Technology and Cost
    9.1 Upstream Source
    9.2 Technology
    9.3 Cost
10 Channel Analysis
    10.1 Market Channel
    10.2 Distributors
11 Consumer Analysis
    11.1  Hospitals Industry 
    11.2   Ambulatory Surgical Centers Industry 
    11.3   Radiology Clinics Industry 
12 Market Forecast 2019-2024
    12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
        12.1.1 Global Therapeutic Nuclear Medicines Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
        12.1.2 Global Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate 2019-2024
        12.1.3 China Therapeutic Nuclear Medicines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        12.1.4 USA Therapeutic Nuclear Medicines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        12.1.5 Europe Therapeutic Nuclear Medicines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        12.1.6 Japan Therapeutic Nuclear Medicines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        12.1.7 Korea Therapeutic Nuclear Medicines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        12.1.8 India Therapeutic Nuclear Medicines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        12.1.9 Southeast Asia Therapeutic Nuclear Medicines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        12.1.10 South America Therapeutic Nuclear Medicines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
        12.3.1 Overall Market Performance
        12.3.2  Beta Emitters Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        12.3.3   Alpha Emitters Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        12.3.4   Brachytherapy Products Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    12.4 Sales by Application 2019-2024
        12.4.1 Overall Market Performance
        12.4.2  Hospitals Sales and and Growth Rate 2019-2024
        12.4.3   Ambulatory Surgical Centers Sales and and Growth Rate 2019-2024
        12.4.4   Radiology Clinics Sales and and Growth Rate 2019-2024
    12.5 Price (USD/Unit) and Gross Profit
        12.5.1 Global Therapeutic Nuclear Medicines Price (USD/Unit) Trend 2019-2024
        12.5.2 Global Therapeutic Nuclear Medicines Gross Profit Trend 2019-2024
13 Conclusion


Inquiry For Buying

Therapeutic Nuclear Medicines Sales

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Therapeutic Nuclear Medicines Sales

Please fill out the form. We will contact you within 24 hours:
All fields required...
Inquiry For Buying

×

Avail Free PDF Sample Report

This website is secure and your personal details are safe. Privacy Policy

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com
-->